Suppr超能文献

谁需要疟疾药物预防?我的个人观点。

Who needs drug prophylaxis against malaria? My personal view.

作者信息

Rombo Lars

机构信息

Department of Infectious Diseases, Mälarsjukhuset Eskilstuna and Karolinska Institute, Stockholm, Sweden.

出版信息

J Travel Med. 2005 Jul-Aug;12(4):217-21. doi: 10.2310/7060.2005.12408.

Abstract

A long tradition of successful malaria prophylaxis with chloroquine led to a dogma that drug prophylaxis should be given regardless of risk as soon as a traveler entered endemic areas. This prevailed also when resistance to chloroquine and adverse effects of alternatives became a problem. A cost/benefit analysis of the risk for malaria versus risk for adverse effects and cost of the recommended drug is not uniformly applied and drug prophylaxis is still advocated even when the risk for severe adverse effects greatly exceeds the risk for malaria, which is unethical.

摘要

长期以来,氯喹在疟疾预防方面的成功应用导致了一种教条,即一旦旅行者进入疟疾流行地区,无论风险如何,都应立即进行药物预防。当出现对氯喹的耐药性以及替代药物的不良反应问题时,这种做法仍然盛行。对于疟疾风险与不良反应风险以及推荐药物成本之间的成本效益分析并未得到统一应用,即使严重不良反应的风险大大超过疟疾风险,药物预防仍被提倡,这是不道德的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验